aTyr Pharma Announces Second Quarter 2020 Results and Provides Corporate Update on ATYR1923 Clinical Trial Programs

NEXT STORY
Ascendis Pharma A/S Announces Second Quarter 2020 Financial Results and Business Update Conference Call on August 27
PREV STORY
KRONOS ADVANCED TECHNOLOGIES ANNOUNCES INCREASED INVENTORIES OF THE COMPANY’S MODEL 8 AND MODEL 5 AIR PURIFIERS
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Roche improves speed and accuracy of non-small cell lung cancer diagnosis with launch of automated digital pathology algorithm

author_avatar
NASDAQ Market News

Orchard Therapeutics Announces New England Journal of Medicine Publication of HSC Gene Therapy Data for ADA-SCID

author_avatar
NASDAQ Market News

NeuBase Therapeutics Demonstrates Functional Rescue in Myotonic Dystrophy Type 1 Model and Allele-Selective Inhibition of KRAS Mutations to Inhibit Tumor Growth

author_avatar
NASDAQ Market News